Abstract. Inflammatory bowel disease (IBD) is a chronic inflammatory disorder which affects the gastrointestinal tract. Many factors, such as genetics, stress, and dietary patterns have been related to the risk of this disease. Adherence to a prudent/...
Abstract: As vitamin D (VD) plays an essential role in inflammatory bowel diseases (IBD), this systematic review aimed to update the participation of this vitamin in the prevention or remission of these diseases. This review has included studies in ...
People affected by Crohn's disease or ulcerative colitis experience a high level of suffering. A new generation of anti-tumour necrosis factor-α agents can alleviate the burden of symptoms considerably. In order to develop a need-centred care programme ...
Standard treatment for IBD with 5-ASA, steroids and immunosuppressants is rather effective and currently optimized using combinations of drugs or application routes. Among the biologics only infliximab has reached the therapeutic arsenal for Crohn's ...
Inflammatory bowel diseases (IBD) show an increase of prevalence in Switzerland. Industrialization and urbanisation correlate with an increase of incidence. IBD are the result of a continuum of interactions between genetic factors, the intestinal ...
Inflammatory Bowel Disease (i. e. Crohn's Disease and Ulcerative Colitis) show a rising incidence throughout Switzerland. An early and individualized therapy usually enables the effective treatment of both diseases and prevents structural gastrointestinal ...
During their disease course, the majority of Crohn's disease patients will develop a complicated disease which is characterized by the occurrence of fistulas and/or stenosis. Symptomatic, perianal fistulas should be surgically drained before anti-...